SC 13G/A | 2024-02-14 | Redmile Group, LLC | Repare Therapeutics Inc. | 2,148,748 | 5.1% | EDGAR |
SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Repare Therapeutics Inc. | 2,992,731 | 7.1% | EDGAR |
SC 13G | 2024-02-14 | Blue Owl Capital Holdings LP | Repare Therapeutics Inc. | 3,122,499 | 7.4% | EDGAR |
SC 13G/A | 2024-01-29 | ARK Investment Management LLC | Repare Therapeutics Inc. | 2,821,560 | 6.7% | EDGAR |
SC 13D/A | 2023-11-17 | BIOTECHNOLOGY VALUE FUND L P | Repare Therapeutics Inc. | 5,309,432 | 12.6% | EDGAR |
SC 13D | 2023-11-03 | BIOTECHNOLOGY VALUE FUND L P | Repare Therapeutics Inc. | 4,662,402 | 11.1% | EDGAR |
SC 13G/A | 2023-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Repare Therapeutics Inc. | 26,894 | 0.1% | EDGAR |
SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | Repare Therapeutics Inc. | 4,443,423 | 10.6% | EDGAR |
SC 13G/A | 2023-02-14 | Redmile Group, LLC | Repare Therapeutics Inc. | 2,684,396 | 6.4% | EDGAR |
SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Repare Therapeutics Inc. | 2,727,606 | 6.5% | EDGAR |
SC 13G/A | 2023-02-13 | CHI Advisors LLC | Repare Therapeutics Inc. | 2,800,126 | 6.7% | EDGAR |
SC 13G/A | 2023-02-10 | ARK Investment Management LLC | Repare Therapeutics Inc. | 2,428,055 | 5.8% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | Repare Therapeutics Inc. | 876,178 | 2.1% | EDGAR |
SC 13D/A | 2023-01-06 | Versant Venture Capital V, L.P. | Repare Therapeutics Inc. | 563,403 | 1.3% | EDGAR |
SC 13D/A | 2022-06-13 | Versant Venture Capital V, L.P. | Repare Therapeutics Inc. | 850,560 | 2.0% | EDGAR |
SC 13G/A | 2022-06-06 | BIOTECHNOLOGY VALUE FUND L P | Repare Therapeutics Inc. | 4,368,757 | 10.4% | EDGAR |
SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Repare Therapeutics Inc. | 2,548,764 | 6.1% | EDGAR |
SC 13G/A | 2022-02-14 | Redmile Group, LLC | Repare Therapeutics Inc. | 2,789,496 | 6.7% | EDGAR |
SC 13G/A | 2022-02-14 | Deep Track Capital, LP | Repare Therapeutics Inc. | 2,100,000 | 5.0% | EDGAR |
SC 13G | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Repare Therapeutics Inc. | 2,166,822 | 5.1% | EDGAR |